TrialJournal of child and adolescent psychopharmacology2015

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.

Michael Aman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.